Dupilumab Improves Clinical Scores in Children and Adolescents With Moderate to Severe Atopic Dermatitis: A Real-World, Single-Center Study. Rathkopf MM. Pediatrics 2023;152.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Rathkopf MM. Dupilumab Improves Clinical Scores in Children and Adolescents With Moderate to Severe Atopic Dermatitis: A Real-World, Single-Center Study. Pediatrics 2023;152.
PMID: 38038567